SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-016602
Filing Date
2017-08-08
Accepted
2017-08-08 17:27:47
Documents
59
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q acor-10q_20170630.htm 10-Q 1361233
2 EX-10.1 acor-ex101_22.htm EX-10.1 101722
3 EX-31.1 acor-ex311_18.htm EX-31.1 16243
4 EX-31.2 acor-ex312_19.htm EX-31.2 15768
5 EX-32.1 acor-ex321_20.htm EX-32.1 6690
6 EX-32.2 acor-ex322_21.htm EX-32.2 6908
  Complete submission text file 0001564590-17-016602.txt   5252251

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT acor-20170630.xml EX-101.INS 1099012
8 XBRL TAXONOMY EXTENSION SCHEMA acor-20170630.xsd EX-101.SCH 31020
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acor-20170630_cal.xml EX-101.CAL 58545
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acor-20170630_def.xml EX-101.DEF 99528
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE acor-20170630_lab.xml EX-101.LAB 325316
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acor-20170630_pre.xml EX-101.PRE 243796
Mailing Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502
Business Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502 914-347-4300
ACORDA THERAPEUTICS INC (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50513 | Film No.: 171015790
SIC: 2836 Biological Products, (No Diagnostic Substances)